682 related articles for article (PubMed ID: 32758188)
1. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
2. [Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)].
Biau J; Miroir J; Millardet C; Saroul N; Pham-Dang N; Racadot S; Huguet F; Kwiatkowski F; Pereira B; Bourhis J; Lapeyre M
Cancer Radiother; 2017 Oct; 21(6-7):527-532. PubMed ID: 28865970
[TBL] [Abstract][Full Text] [Related]
3. Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial.
Biau J; Lopez L; Thivat E; Casile M; Millardet C; Saroul N; Pham-Dang N; Molnar I; Bourhis J; Lapeyre M
Clin Transl Radiat Oncol; 2023 Jan; 38():169-174. PubMed ID: 36466746
[TBL] [Abstract][Full Text] [Related]
4. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
5. Post radiation mucosal ulcer risk after a hypofractionated stereotactic boost and conventional fractionated radiotherapy for oropharyngeal carcinoma.
Verduijn GM; Petit SF; Lauwers I; van Norden Y; Sijtsema ND; Sewnaik A; Mast H; Capala M; Nout R; Baker S; van Meerten E; Hoogeman MS; van der Lugt A; Heemsbergen WD
Acta Oncol; 2023 Jan; 62(1):40-47. PubMed ID: 36576773
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer.
Vempati P; Halthore AN; Teckie S; Rana Z; Gogineni E; Antone J; Zhang H; Marrero M; Beadle K; Frank DK; Aziz M; Paul D; Ghaly M
Radiat Oncol; 2020 Dec; 15(1):278. PubMed ID: 33308265
[TBL] [Abstract][Full Text] [Related]
7. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol.
Lee J; Nguyen NT; Wright J; Yeung KD; Sagar S; Kim DH; Ostapiak O; Doerwald-Munoz L; Whelan T
BMC Cancer; 2023 Apr; 23(1):379. PubMed ID: 37098494
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
10. Selective use of postoperative neck radiotherapy in oral cavity and oropharynx cancer: a prospective clinical study.
Martínez Carrillo M; Tovar Martín I; Martínez Lara I; Ruiz de Almodóvar Rivera JM; Del Moral Ávila R
Radiat Oncol; 2013 Apr; 8():103. PubMed ID: 23621873
[TBL] [Abstract][Full Text] [Related]
11. ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.
Zilli T; Scorsetti M; Zwahlen D; Franzese C; Förster R; Giaj-Levra N; Koutsouvelis N; Bertaut A; Zimmermann M; D'Agostino GR; Alongi F; Guckenberger M; Miralbell R
Radiat Oncol; 2018 Sep; 13(1):166. PubMed ID: 30180867
[TBL] [Abstract][Full Text] [Related]
12. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
14. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692
[TBL] [Abstract][Full Text] [Related]
15. A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.
Holyoake DL; Ward E; Grose D; McIntosh D; Sebag-Montefiore D; Radhakrishna G; Patel N; Silva M; Mukherjee S; Strauss VY; Odondi L; Fokas E; Melcher A; Hawkins MA
BMC Cancer; 2016 Sep; 16(1):728. PubMed ID: 27619800
[TBL] [Abstract][Full Text] [Related]
16. Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial.
Jiang P; Krockenberger K; Vonthein R; Tereszczuk J; Schreiber A; Liebau S; Huttenlocher S; Imhoff D; Balermpas P; Keller C; Dellas K; Baumann R; Rödel C; Hildebrandt G; Jünemann KP; Merseburger AS; Katz A; Ziegler A; Blanck O; Dunst J
Radiat Oncol; 2017 Aug; 12(1):138. PubMed ID: 28821268
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.
Martínez-Monge R; Gómez-Iturriaga A; Cambeiro M; Garrán C; Montesdeoca N; Aristu JJ; Alcalde J
Brachytherapy; 2009; 8(1):26-33. PubMed ID: 19041280
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.
Peters LJ; Goepfert H; Ang KK; Byers RM; Maor MH; Guillamondegui O; Morrison WH; Weber RS; Garden AS; Frankenthaler RA
Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):3-11. PubMed ID: 8482629
[TBL] [Abstract][Full Text] [Related]
19. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost.
Blažek T; Zděblová Čermáková Z; Knybel L; Hurník P; Štembírek J; Resová K; Paračková T; Formánek M; Cvek J; Soumarová R
Radiat Oncol; 2021 Jun; 16(1):122. PubMed ID: 34187494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
